MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
MASI stock logo

MASI

Masimo Corporation

$178.59
0.58
 (0.33%)
Exchange:  NASDAQ
Market Cap:  9.593B
Shares Outstanding:  52.8M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Instruments & Supplies
   
CEO:  Catherine Szyman
Full Time Employees:  3600
Address: 
52 Discovery
Irvine
CA
92618
US
Website:  https://www.masimo.com
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain’s electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/06 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue2,048,1002,094,4001,526,900
Gross Profit1,003,5001,004,400945,200
EBITDA236,700-158,700344,600
Operating Income136,500-266,700312,800
Net Income81,500-304,900-151,500

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets3,041,5002,625,7001,698,900
Total Liabilities1,676,7001,573,800977,700
Total Stockholders Equity1,364,8001,051,900721,200
Total Debt970,000846,100518,000
Cash and Cash Equivalents163,000177,600152,300

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow94,100196,400217,200
Capital Expenditure-44,000-20,000-19,400
Free Cash Flow6,400176,400197,800
Net Income81,500-304,900-151,500
Net Change in Cash-41,40013,2000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)1,964,518.261Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)1,985,680.564Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)1,974,600Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)271,246.308Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)274,168.244Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)272,638.321Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)400,032.863Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)405,643.647Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)402,706.007Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)649,362.627Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)656,357.730Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)652,695.100Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)7.430Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)7.480Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)7.380Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)1Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
2.094B  ?P/S
 (TTM)
: 
6.12
?Net Income
 (TTM)
: 
-304900000  ?P/E
 (TTM)
: 
-63.11
?Enterprise Value
 (TTM)
: 
9.748B  ?EV/FCF
 (TTM)
: 
49.79
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
-0.17  ?ROIC
 (TTM)
: 
0.18
?Net Debt
 (TTM)
: 
665.8M  ?Debt/Equity
 (TTM)
: 
0.78
?P/B
 (TTM)
: 
13.26  ?Current Ratio
 (TTM)
: 
2.49

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
32.47Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates MASI intrinsic value between $45.96 – $48.70 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate MASI Intrinsic Value

Common questions about MASI valuation

Is Masimo Corporation (MASI) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Masimo Corporation (MASI) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is MASI a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether MASI trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is MASI’s P/E ratio?

You can see MASI’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for MASI?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is MASI a good long-term investment?

Whether MASI fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

MASI

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

0.33
MARKETSnap

Trading Metrics:

Open: 177.78   Previous Close: 178.01
Day Low: 177.77   Day High: 178.65
Year Low: 125.94   Year High: 179
Price Avg 50: 162.95   Price Avg 200: 151.41
Volume: 1.007M   Average Volume: 1.656M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

American Century Companies Inc. Boosts Position in Masimo Corporation $MASI
09-03-2026 03:02
American Century Companies Inc. Boosts Position in Masimo Corporation $MASI
Halper Sadeh LLC is Investigating Whether MASI and KW are Obtaining Fair Deals for their Shareholders
25-02-2026 16:43
Halper Sadeh LLC is Investigating Whether MASI and KW are Obtaining Fair Deals for their Shareholders
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI
18-02-2026 20:30
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI
What's Happening With Masimo Stock?
18-02-2026 09:25
What's Happening With Masimo Stock?
Strength Seen in Masimo (MASI): Can Its 34.2% Jump Turn into More Strength?
18-02-2026 05:10
Strength Seen in Masimo (MASI): Can Its 34.2% Jump Turn into More Strength?
MASI Stock Alert: Halper Sadeh LLC is Investigating Whether Masimo Corporation is Obtaining a Fair Price for Its Shareholders
17-02-2026 09:30
MASI Stock Alert: Halper Sadeh LLC is Investigating Whether Masimo Corporation is Obtaining a Fair Price for Its Shareholders

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read